A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
Clinical trial NCT04444466 · TERMINATED
Trial details
- NCT number
- NCT04444466
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-08-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.